文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell response
侵权投诉

Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell response

Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell response

Articles

Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses

Sharad Shrestha1,2,5, Kai Yang1,5, Cliff Guy1, Peter Vogel3, Geoffrey Neale4 & Hongbo Chi1,2

The interplay between effector T cells and regulatory T cells (Treg cells) is crucial for adaptive immunity, but how Treg cells control diverse effector responses is elusive. We found that the phosphatase PTEN links Treg cell stability to repression of type 1 helper T cell (TH1 cell) and follicular helper T cell (TFH cell) responses. Depletion of PTEN in Treg cells resulted in excessive TFH cell and germinal center responses and spontaneous inflammatory disease. These defects were considerably blocked by deletion of interferon-g, indicating coordinated control of TH1 and TFH responses. Mechanistically, PTEN maintained Treg cell stability and metabolic balance between glycolysis and mitochondrial fitness. Moreover, PTEN deficiency upregulates activity of the metabolic checkpoint kinase complex mTORC2 and the serine-threonine kinase Akt, and loss of this activity restores functioning of PTEN-deficient Treg cells. Our studies establish a PTEN-mTORC2 axis that maintains Treg cell stability and coordinates Treg cell–mediated control of effector responses.The interplay between immune regulatory mechanisms and effector T cell responses is a crucial determinant of adaptive immunity. Among multiple regulatory systems, thymus-derived Treg cells marked by the transcription factor Foxp3 have a central role in maintaining self-tol-erance and preventing autoimmune disease. Recent genetic studies highlight that Treg cells employ distinct transcriptional programs to control effector TH1, TH2 and TH17 cell responses1,2. Specifically, Treg cells expressing the transcription factors T-bet, IRF4 and STAT3 orchestrate the control of effector TH1, TH2 and TH17 cell responses respectively3–5. Owing to their potent suppressive activity and func-tional diversity, the stability of Treg cells is actively maintained by Foxp3-dependent and independent mechanisms6,7. However, under certain inflammatory conditions, Treg cells could lose Foxp3 expres-sion and lineage stability and acquire effector functions8–11. Studies also demonstrate the heterogeneity of Treg cells distinguished by the expression of IL-2 receptor-α (CD25), the chemokine receptor CCR7 and other molecules12–14. Defining the mechanisms involved in the functional diversification and lineage stability of Treg cells is crucial for understanding immune system regulation.

TFH cells are a subset of CD4+ T cells specialized in providing help to B cells for the formation of germinal center (GC) reactions and the development of humoral immunity15. Excessive TFH cell responses, however, lead to the development of autoimmune diseases including systemic lupus erythematosus (SLE)15,16. TFH cells are characterized by the preferential expression of the chemokine receptor CXCR5, the costimulatory molecule ICOS, the inhibitory molecule PD-1 and the cytokine IL-21. Differentiation of TFH cells requires the interac-tion with antigen-presenting cells including dendritic cells and B cells and is further programmed by lineage-specific transcription factors including Bcl6 and Ascl2 (refs. 15,17). Furthermore, TFH responses

are restrained by a specific Treg cell subset, follicular regulatory T cells (TFR cells), in a Bcl6-dependent manner. TFR cells share phenotypic features with both thymus-derived Treg and TFH cells, as shown by the concomitant expression of Foxp3, CTLA4, GITR, Bcl6, ICOS, PD-1 and CXCR5, but are functionally distinct from these conventional populations18,19. The molecular pathways that orchestrate the genera-tion and function of TFR cells and the interplay with other effector cells have remained unclear.

Emerging studies reveal a central role of mechanistic target of rapamycin (mTOR), a signaling pathway that integrates immune and metabolic cues, in T cell–mediated immune responses20,21. mTOR signaling is comprised of mTOR complex 1 (mTORC1) and mTORC2, distinct complexes that have unique contributions to effector

22–2425T cell responses, and functional fitness of Treg cells. Because

of the potent effects of mTOR signaling on T cell responses, multiple mechanisms have evolved to actively suppress mTOR signaling20. For instance, loss of the tumor suppressor Tsc1 aberrantly upregulates mTORC1 activity and disrupts T cell quiescence, homeostasis and function26. T cell–specific deletion of PTEN, an upstream inhibi-tor of lipid kinase PI(3)K-Akt signaling, leads to the development of leukemia and autoimmunity27,28. As a pluripotent molecule, PTEN antagonizes PI(3)K activity and thus inhibits mTORC1 and mTORC2 activity20; PTEN also possesses nuclear functions independent of PI(3)K-Akt activity29. Although PTEN has been implicated in Treg cells from mice and humans30–32, Treg cells deficient in PTEN show largely normal suppressive activity in vitro33. Therefore, the func-tional impacts and molecular pathways of PTEN in Treg cell–mediated immune homeostasis and function remain to be established.

To investigate the in vivo functions and mechanisms of PTEN in Treg cells, we have developed a mouse model to delete PTEN selectively

p© 2015 Nature America, Inc. All rights reserved.

Health Science Center, Memphis, Tennessee, USA. 3Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA. 4Hartwell Center for Bioinformatics and Biotechnology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA. 5These authors contributed equally to this work. Correspondence should be addressed to H.C. (hongbo.chi@stjude.org).

Received 22 July 2014; accepted 1 December 2014; published online 5 January 2015; doi:10.1038/ni.3076

1Department of Immunology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA. 2Integrated Biomedical Sciences Program, University of Tennessee

178 VOLUME 16 NUMBER 2 FEBRUARY 2015

Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell response

nature immunology

第1页

你可能喜欢

热门文档

相关文档

  • Treg细胞与肿瘤免疫

    “首先报导CD4+CD25+T(Treg)细胞以来,关于Treg细胞的研究已成为免疫学界的热门课题之一。Treg细胞是具有免疫调节作用的T细胞亚群,其中Treg细胞与肿瘤免疫的研究更...

  • Treg

    Treg_自然科学_专业资料。CD 4+CD 25+调节性 T 细胞 CD4+CD25+调节性 T 细胞(Treg)首次由日本学者 Sakaguchi 等于 1995 年 所报道,这类 T 细胞介导的...

  • Treg 研究方法指南

    Treg 研究方法指南_医药卫生_专业资料。Treg 细胞研究方法及相关产品 报告内容 一、研究背景 二、Treg细胞发育 三、Treg细胞功能 四、研究意义 五、Th细胞亚群...

  • Treg

    Treg_医学_高等教育_教育专区。TregT-reg 细胞 5分开放分类: 开放分类:免疫学免疫系统生物细胞 收藏分享到顶[8]编辑词条 新知社新浪微博人人网腾讯微博移动说客...

  • PBMC_Treg检测

    PBMC_Treg检测_生物学_自然科学_专业资料。外周血 Treg 表型及功能指标测定(用 1640 稀释外周血) 1、标记笔标记流式管 1、2、3、4。 2、流式管 1、2、...

  • treg的调节作用

    天然的 CD4 +CD25+Treg 细胞来源于胸腺 CD4+CD25+T 细胞除了在胸腺产生以外,还可以在未成熟的树突状细胞、 IL-10、 IFN-a、 TGF-beta 或者低剂量抗原诱导...

  • Th17细胞和Treg细胞在原发性肝癌中的表达及与肿瘤进展...

    第二军医大学 硕士学位论文 Th17细胞和Treg细胞在原发性肝癌中的表达及与肿瘤进展的关 系 姓名:王维维 申请学位级别:硕士 专业:临床检验诊断学 指导教师:沈茜 ...

  • 34王福生Treg细胞与CD8关系及不良预后相关

    Conclusions: Increased CD4 CD25 FoxP3 Treg may impair the effector function of CD8 T cells, promote disease progression, and represent both a potential ...

  • 调节性T细胞与免疫耐受

    综 述? 调节性T细胞与免疫耐受闫峰综述,黄振平审校(南京军区南京总医院眼科,江苏南京210002) 摘要:调节性T细胞(Treg)在诱发免疫耐受和治疗自身免疫性疾病中起重要...

  • Treg细胞与Th17细胞的研究现状及临床意义

    Th17细胞与Treg细胞免疫... 68页 1下载券Treg细胞与Th17细胞的研究现状及临...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email